Manufacturer of Controlled Substances; Notice of Registration, 48557 [E6-13724]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 161 / Monday, August 21, 2006 / Notices
be sent to DEA Headquarters, Attention:
DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than September 20, 2006.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
Schedule I or II are, and will continue
to be required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 1301.34(b), (c), (d), (e) and (f) are
satisfied.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Noramco Inc. to manufacture the listed
basic classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated
Noramco Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: August 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–13727 Filed 8–18–06; 8:45 am]
Dated: August 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–13724 Filed 8–18–06; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF LABOR
Drug Enforcement Administration
Employment and Training
Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated April 18, 2006, and
published in the Federal Register on
April 25, 2006, (71 FR 23950), Noramco
Inc., 1440 Olympic Drive, Athens,
Georgia 30601, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
Schedules I and II:
Drug
Schedule
hsrobinson on PROD1PC72 with NOTICES
Codeine-N-oxide (9053) ...............
Morphine-N-oxide (9307) ..............
Amphetamine (1100) ....................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) .................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Thebaine (9333) ...........................
Sufentanil (9740) ..........................
Fentanyl (9801) .............................
I
I
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the Schedule I
controlled substances for internal
testing; the Schedule II controlled
substances will be manufactured in bulk
for distribution to its customers.
VerDate Aug<31>2005
17:53 Aug 18, 2006
Jkt 208001
Implementing the Salary and Bonus
Limitations in Public Law 109–234
Employment and Training
Administration, Labor.
ACTION: Notice.
AGENCY:
SUMMARY: This notice provides
information regarding implementing
salary and bonus limitations in Public
Law 109–234. It is directed to all
Employment and Training
Administration (ETA) grantees,
contractors and other recipients of ETA
appropriated funds. The purpose of this
Notice is to inform States and other
ETA-fund recipients and sub-recipients
of a new limitation on salary and bonus
payments that can be made with funds
appropriated to ETA and provide
guidance on implementing this new
provision.
SUPPLEMENTARY INFORMATION:
I. References
Public Law 109–234.
II. Background
On June 15, 2006, President Bush
signed into law an emergency
supplemental appropriations bill, Public
Law 109–234. Section 7013 of this
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
48557
public law limits salary and bonus
compensation for individuals who are
paid by funds appropriated to the
Employment and Training
Administration and provided to
recipients and sub-recipients.
Specifically, section 7013 states:
None of the funds appropriated in Public
Law 109–149 or prior Acts under the heading
‘‘Employment and Training’’ that are
available for expenditure on or after the date
of enactment of this section shall be used by
a recipient or subrecipient of such funds to
pay the salary and bonuses of an individual,
either as direct costs or indirect costs, at a
rate in excess of Executive Level II, except as
provided for under section 101 of Public Law
109–149. This limitation shall not apply to
vendors providing goods and services as
defined in OMB Circular A–133. Where
States are recipients of such funds, States
may establish a lower limit for salaries and
bonuses of those receiving salaries and
bonuses from subrecipients of such funds,
taking into account factors including the
relative cost-of-living in the State, the
compensation levels for comparable State or
local government employees, and the size of
the organizations that administer Federal
programs involved including Employment
and Training Administration programs.
III. Policy Guidance
This policy guidance provides the
workforce investment system with
information on programs that are
impacted by this provision; the effective
date and cycles of funding that are
impacted; covered individuals and
transactions; the application of the
limitation; related grant and contract
modifications; action required; and
where to direct inquiries.
IV. Programs Impacted by This
Provision
The new salary and bonus limitation
applies to all programs and activities
undertaken through grants and contracts
funded by an appropriation to ETA.
Therefore, this limitation applies to all
programs administered by ETA, unless
the program falls within an exception
outlined below.
The salary and bonus limitation also
applies to programs funded by an ETA
appropriation, but administered by
another agency. For example, certain
programs funded by ETA appropriations
are administered by the Department of
Labor’s Veterans Employment and
Training Service or the Department of
the Interior. ETA will inform agencies
which administer such programs of this
new requirement. Any questions should
be directed to the administering agency.
A recipient or sub-recipient may
receive funds from ETA that are a
combination of funds appropriated to
ETA and funds that are not appropriated
to ETA. In this situation, the limitations
E:\FR\FM\21AUN1.SGM
21AUN1
]]>Agencies
[Federal Register Volume 71, Number 161 (Monday, August 21, 2006)]
[Notices]
[Page 48557]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-13724]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated April 18, 2006, and published in the Federal
Register on April 25, 2006, (71 FR 23950), Noramco Inc., 1440 Olympic
Drive, Athens, Georgia 30601, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in
Schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Codeine-N-oxide (9053)...................... I
Morphine-N-oxide (9307)..................... I
Amphetamine (1100).......................... II
Codeine (9050).............................. II
Dihydrocodeine (9120)....................... II
Oxycodone (9143)............................ II
Hydromorphone (9150)........................ II
Hydrocodone (9193).......................... II
Morphine (9300)............................. II
Thebaine (9333)............................. II
Sufentanil (9740)........................... II
Fentanyl (9801)............................. II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the Schedule I
controlled substances for internal testing; the Schedule II controlled
substances will be manufactured in bulk for distribution to its
customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Noramco Inc. to manufacture the listed basic classes of controlled
substances is consistent with the public interest at this time. DEA has
investigated Noramco Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above
named company is granted registration as a bulk manufacturer of the
basic classes of controlled substances listed.
Dated: August 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-13724 Filed 8-18-06; 8:45 am]
BILLING CODE 4410-09-P
